Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several components of the budding yeast pheromone-response pathway are conserved in mammalian mitogen-activated protein (MAP) kinase pathways. Thus, we used degenerate oligonucleotides derived from the sequence of the Saccharomyces cerevisiae protein kinase Ste20p to amplify related sequences from the rat. One of these sequences was used to clone a rat Ste20p homolog, which we called
TAO1
for its one thousand and one amino acids. Northern analysis shows
TAO1
is highly expressed in brain, as is a homolog TAO2. Recombinant
TAO1
was expressed and purified from Sf9 cells. In vitro, it activated MAP/extracellular signal-regulated protein kinase (ERK) kinases (MEKs) 3, 4, and 6 of the stress-responsive MAP kinase pathways, but not
MEK1
or 2 of the classical MAP kinase pathway.
TAO1
activated MEK3 but not MEK4 or MEK6 in transfected cells. MEK3 coimmunoprecipitated with
TAO1
when they were expressed in 293 cells. In addition, immunoreactive MEK3 endogenous to Sf9 cells copurified with
TAO1
produced from a recombinant baculovirus. The activation of and binding to MEK3 by
TAO1
implicates
TAO1
in the regulation of the p38-containing stress-responsive MAP kinase pathway.
...
PMID:Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades. 978 55